key: cord-0836459-z59yqi3s authors: Watanabe, Mikiko; Caruso, Damiano; Tuccinardi, Dario; Risi, Renata; Zerunian, Marta; Polici, Michela; Pucciarelli, Francesco; Tarallo, Mariarita; Strigari, Lidia; Manfrini, Silvia; Mariani, Stefania; Basciani, Sabrina; Lubrano, Carla; Laghi, Andrea; Gnessi, Lucio title: Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19 date: 2020-07-23 journal: Metabolism DOI: 10.1016/j.metabol.2020.154319 sha: 7d457c3c6b3b43b85285d083a52419a59fc18bd9 doc_id: 836459 cord_uid: z59yqi3s BACKGROUND: Obesity was recently identified as a major risk factor for worse COVID-19 severity, especially among the young. The reason why its impact seems to be less pronounced in the elderly may be due to the concomitant presence of other comorbidities. However, all reports only focus on BMI, an indirect marker of body fat. Aim To explore the impact on COVID-19 severity of abdominal fat as a marker of body composition easily collected in patients undergoing a chest CT scan. METHODS: Patients included in this retrospective study were consecutively enrolled among those admitted to an Emergency Department in Rome, Italy, who tested positive for SARS-Cov-2 and underwent a chest CT scan in March 2020. Data were extracted from electronic medical records. RESULTS: 150 patients were included (64.7% male, mean age 64 ± 16 years). Visceral fat (VAT) was significantly higher in patients requiring intensive care (p = .032), together with age (p = .009), inflammation markers CRP and LDH (p < .0001, p = .003, respectively), and interstitial pneumonia severity as assessed by a Lung Severity Score (LSS) (p < .0001). Increasing age, lymphocytes, CRP, LDH, D-Dimer, LSS, total abdominal fat as well as VAT were found to have a significant univariate association with the need of intensive care. A multivariate analysis showed that LSS and VAT were independently associated with the need of intensive care (OR: 1.262; 95%CI: 1.0171–1.488; p = .005 and OR: 2.474; 95%CI: 1.017–6.019; p = .046, respectively). CONCLUSIONS: VAT is a marker of worse clinical outcomes in patients with COVID-19. Given the exploratory nature of our study, further investigation is needed to confirm our findings and elucidate the mechanisms underlying such association. J o u r n a l P r e -p r o o f 4 complications. Moreover, such findings could pave the way to better understanding the mechanisms underlying the established link between body weight and COVID-19 severity. We therefore aimed at investigating the association of VAT deposition with clinical outcomes such as the need of intensive care among patients with COVID-19. Patients included in this single center retrospective study were consecutively enrolled among those admitted to the Emergency Department of Sant'Andrea Hospital, Rome, Italy, who tested positive for SARS-Cov-2 and underwent a chest CT scan in March 2020. All patients were subjected to two naso-and oro-pharyngeal swabs at a 24-hour interval, and the specimen were tested to confirm SARS-COV2 diagnosis through realtime reverse transcriptase (RT-PCR) (Charitè, Berlin, Germany). Deidentified data about demographic and clinical characteristics were collected, together with laboratory data on presentation. Data were extracted from electronic medical records. Based on the clinical and radiological assessment, the patients were subsequently addressed from the Emergency Department towards home discharge or admitted to sub-intensive or Intensive Care Unit (ICU), and such clinical outcome was recorded for the purposes of this study. All patients accessing the ICU were intubated and underwent invasive mechanical ventilation, whereas those in subintensive care did not need intubation. Patients whose CT could not be evaluated due to severe motion artifact or other technical issues such as restricted field of view for adipose tissue quantification or CT acquired with contrast medium were excluded, as well as those for whom investigated clinical outcomes were unavailable. The study was approved by the local institutional review board (IRB), and written informed consent was obtained from all study participants. When patients were unable to provide informed consent, this was received by the next-of-kin or admitting physician. J o u r n a l P r e -p r o o f 5 Based on a preliminary pilot study of 20 patients, the mean ± SD VAT in the patient population was 14000 ± 8500 mm 2 . Assuming a power of 0.80 and alpha of 0.05, 142 patients were considered appropriate to highlight an expected difference of 2000 mm 2 in the VAT value. The number of subjects was further increased to 150 to prevent possible missing data. Assuming an alpha of 0.05, the post-hoc power calculated considering the mean ± SD VAT in the investigated groups with the smaller number of patients (i.e., 23) was 89.2%. 2.3 CT Acquisition Technique and Lung Severity Score evaluation COVID-19 positive patients underwent a chest CT scan to determine the pulmonary involvement. The acquisitions were obtained on a 128-slice CT (GE Revolution EVO, GE Medical Systems, Milwaukee, WI, USA). Lung impairment was evaluated through a Lung Severity Score (LSS) calculated through visual assessment by two expert radiologists in consensus (DC and MZ with 10 and 5 years of experience respectively) ranging from 0 to 40 (Figure 1 A-B ) [17] . Briefly, each lung was divided in 10 regions as already described [18] , and for each region a visual score of parenchymal involvement was assigned (ground-glass opacities and consolidation), with a score 0 for absence, 1 for < 50% and 2 for > 50% lung involvement. Measurements were performed by two radiologists in consensus (MP and FP with 6 and 7 years of experience respectively) on a commercially available workstation computer were the chest CTs had been transferred (Advantage Windows Workstation, version 4.7, GE Healthcare). To quantify abdominal visceral and subcutaneous fat, the first slice where lung bases were no more visible at the thoracoabdominal level was selected, adapting from a previously described method (Figure 1 C) [19] . A region of interest (ROI) of the body circumference avoiding subcutaneous tissue was identified; then a HU range corresponding to the CT histogram of adipose tissue from -250 to -50 HU was set to automatically calculate the visceral adipose tissue (VAT) area expressed in mm 2 on the J o u r n a l P r e -p r o o f 6 selected slice (Figure 1 D) . The procedure was repeated drawing a ROI including the subcutaneous tissue and obtaining the total adipose tissue (TAT) area expressed in mm 2 . Subcutaneous adipose tissue (SAT) area expressed in mm 2 was obtained as the subtraction between TAT and VAT. Finally, epicardial fat thickness (EFT) was measured at the level of the right coronary artery origin on the axial plane. To reduce bias, measurements were assessed three times and a mean of the values was recorded, expressed in millimeters. The Statistical Package for Social Sciences (SPSS), v.20, and R-package (Vienna, Austria) were used for statistical analysis. Results are presented as mean ± standard deviation (SD). Normality was assessed with the Kolmogorov-Smirnov test. Variables not normally distributed were log-transformed. Patients were categorized in three groups based on the type of treatment (Home discharge, Sub-intensive Care, and ICU). The primary endpoint was admission to ICU, which includes requirement for intubation. For continuous variables, a one-way ANCOVA was conducted to compare the distribution of the clinical, biochemical and CT-derived adiposity parameters and LSS among the three different levels of care controlling for age and gender, and a post-hoc multiple comparison LSD adjusted was conducted. Chi-Square test/Fisher's exact test was used for categorical variables. Pearson's correlation coefficient was used to investigate the level of association between continuous variables. To assess the presence of additive interaction of investigated variables on ICU admission, three indices were calculated [20] using the R-package "interactionR": (1) the relative excess risk due to interaction (RERI), (2) the proportion of disease among those with both exposures that is attributable to their interaction (AP), and (3) the synergy index (SI). A RERI of one means no interaction or perfect additivity. A RERI of greater than one means positive interaction or more than additivity. A RERI of less than one means negative interaction or less than additivity. RERI ranges from zero to infinity. An AP of zero means no interaction or perfect additivity. An AP greater than zero means positive J o u r n a l P r e -p r o o f 7 interaction or more than additivity. An AP of less than zero means negative interaction or less than additivity. AP ranges from -1 to +1. The SI is the ratio of the combined effects and the individual effects. An SI of one means no interaction or perfect additivity. An SI of greater than one means positive interaction or more than additivity. An SI of less than one means negative interaction or less than additivity. SI ranges from zero to infinity. The confidence interval for the three additive interaction measures were calculated according Hosmer et al. [21] . In figure 2B The effect estimate is reported as Nagelkerke's R 2 , which informs on how much the model explains the variance of the dependent variable. The ORs represent the mean change in the dependent variable per one unit of change in the independent variable while holding other predictors in the model constant. Variance inflation factor (VIF) values were lower than 4.0, suggesting the absence of multicollinearity between included variables [22] . The results were considered statistically significant when p < 0.05. ICU admission was used as the gold standard for nonparametric clustered receiver operating characteristic (ROC) analysis to evaluate the predictive utility of the models. By comparing observed and calculated ICU admission, sensitivity and specificity were plotted in ROC form. When a perfect correlation of predicted versus observed ICU admission was found, the ROC area under curve (AUC) was equal to 1, whereas random assignment of outcome led to an AUC of 0.5. One hundred and fifty patients were enrolled, 64.7% male, with a mean ± SD age of Upon categorization by VAT quartiles, a rise in ICU admission was observed with increasing VAT accumulation (p=0.009; Figure 2A) , and patients belonging to the highest VAT quartile required ICU admission significantly more than those in the second VAT quartile (p=0.026) (Figure 2A) . Stratifying by age, 65 years being the median age of the study population, RERI, AP, and SI, reflecting the interaction between age and VAT accumulation in contributing to ICU admission, consistently indicated a positive interaction on an additive scale, meaning that the combined effect of age and VAT seems to be more than the sum of the effects (1.75, 0.43, and 2.32, respectively, supplementary Table 1 ). However, this interaction was not significant (p=ns, Figure 2B ). On an exploratory basis, we further performed a subgroup analysis and observed a trend increased need of ICU admission per higher VAT accumulation in the age group >65 years (p=0.084, Figure 2B) ; within this subgroup, a significant difference was observed between the fourth and second VAT quartile (p=0.0394, Figure 2B) . Table 2) , however, once again the interaction term was not significant (p=ns, Figure 2C ). The exploratory subgroup investigation showed that male subjects confirmed what observed in the general population (p=0.025, Figure 2C) ; conversely, female subjects did not confirm this finding (p=0.249, Figure 2 C) . Within the male subgroup, subjects with VAT belonging to the fourth quartile were significantly more in need of ICU admission compared to those in the second quartile (p=0.0126, Figure 2C ). Upon stratification by LSS, RERI, AP, and SI, suggested a positive interaction on an additive scale between VAT accumulation and LSS (3.67, 0.42, and 1.88, respectively, Supplementary Table 3) , but once again the interaction term was not significant (p=ns, Figure 2D ). However, the explorative subgroup analysis suggested that patients in the high LSS group (when LSS was higher than the LSS median value) and belonging to the highest quartile of VAT deposition were admitted to ICU more frequently (0.022 for high LSS, Figure 2D ). Patients in the low LSS group did not confirm this finding (p=0.431, Figure 2D ). We report that visceral deposition of fat within the abdomen is independently associated with worse clinical outcomes upon SARS-CoV-2 infection. Interestingly, VAT accumulation seems to have a stronger link with the need of ICU admission and therefore intubation as opposed to other relevant parameters, such as severity of interstitial pneumonia, markers of inflammation, age, gender or comorbidities. Upon stratification, it seems that higher VAT is associated with an increased need of intensive care in subjects over 65 and in male gender, and among those with high LSS, having higher VAT is associated with increased ICU admission. However, it should be noted that the number of patients requiring ICU admission in each subgroup was small leading to non-significant interaction terms between subgroups (gender, age, severity score). Subgroup analysis needs therefore to be considered exploratory and should be taken with caution, but it can lay the path for future studies. The pathophysiology underlying the suggested link is likely multi-stranded. First, obesity is associated with complement system hyperactivation, chronic inflammation, and presence of comorbidities such as diabetes and hypertension proposed in turn to be risk factors for COVID-19 poor prognosis [27] . Furthermore, visceral adipose tissue is capable of secreting Interleukin-6 [28] , whose levels were found to be retrospectively increased in COVID-19 non-survivors [25] . SARS-CoV-2 seems to infect cells through an Angiotensinconverting enzyme 2 (ACE2)-dependent mechanism, a receptor also expressed by fat, including ectopic reservoirs [29] , and an additional direct proinflammatory role of COVID-19 in the adipose tissue may therefore possibly contribute to the observed results. Although the design of our study does not allow for a causal relationship to be found, our findings led us to hypothesize that VAT accumulation may work behind the scenes to cause some of the conditions currently suggested to be risk factors for poor prognosis. Noteworthy, our results are in line with a previous report suggesting that ectopic fat deposition within the liver is strongly associated to COVID-19 clinical severity among obese subjects [30] . However, Non-Alcoholic Fatty Liver Disease is hard to be diagnosed as a chest CT scan only is performed in COVID-19 patients, and our findings are therefore more likely to produce an immediate clinical impact. Among the great variety of ectopic fat deposition sites, epicardial fat represents a marker of systemic inflammation [31] , and a role has been hypothesized in the worse evolution of patients with COVID-19 and obesity [32, 33] . Interestingly, no correlation was observed with pulmonary disease severity, hinting that this specific reservoir may have no role in the increased need of intubation correlated with obesity, possibly retaining one in cardiac manifestations related to COVID-19, which were not investigated in the present study. Our study has several limitations. First, the sample size was relatively small, leading to small subgroup sizes upon stratification analysis by age or gender. However, the sample size exceeded that calculated based on a preliminary pilot study, and the posthoc power was 89.2%. The nature of this study was retrospective, and only selected biochemical and clinical parameters were available, together with a partial clinical history, J o u r n a l P r e -p r o o f 13 making correction for some possible confounders not possible. Also, other hard outcomes such as mortality could not be retrieved in the study population, as many patients were transferred to other COVID centers due to governmental directives. Moreover, anthropometric parameters (i.e. BMI) were unavailable, and a comparison in outcomes prediction was therefore not performed. Furthermore, this was not a mechanistic study, and the pathophysiology underlying the findings, possibly involving the inflammatory role of visceral adipocytes, could not be clarified. Some strengths should also be acknowledged. The age distribution of our study population was wider than that of many reports. Moreover, not only the need of intubation was available, but also a categorization between patients in need of subintensive care as opposed to those whose clinical conditions were good enough to be discharged for home monitoring could be retrieved. Finally, to the best of our knowledge, this is the first study investigating fat deposition, thus indirectly body composition, in patients with COVID-19, and the assessed markers did not require additional instrumental tests, leading to a possible immediate clinical applicability. In conclusion, our preliminary findings suggesting that increased visceral accumulation of fat is associated with worse COVID-19 severity might aid in further confirmatory studies, on the one hand investigating VAT as a useful clinical marker, and on the other hand elucidating the underlying pathophysiology. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation ICNARC report on COVID-19 in critical care Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality World Health Organization. Health topics Obesity treatment within the Italian national healthcare system tertiary care centers: what can we learn? Eat Weight Disord Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission Obesity could shift severe COVID-19 disease to younger ages Obesity and COVID-19: an Italian snapshot Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50 Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999-2004 Measuring body fat distribution and content in humans Inflammation and metabolic disorders Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages Chest CT Features of COVID-19 in Optimization of window settings for standard and advanced virtual monoenergetic imaging in abdominal dual-energy CT angiography Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19 Visceral fat measured by computed tomography and the risk of breast cancer Estimating measures of interaction on an additive scale for preventive exposures Confidence interval estimation of interaction Multivariate data analysis Clinical features of patients infected with 2019 novel coronavirus in Wuhan Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Structure analysis of the receptor binding of 2019-nCoV Obesity and SARS-CoV-2: a population to safeguard Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium Obesity accompanying COVID-19: the role of epicardial fat Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?